Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 93 publications
Zolbetuximab plus pembrolizumab and chemotherapy in CLDN18.2-positive, HER2-negative, PD-L1-positive gastric or gastroesophageal junction adenocarcinoma: randomized, double-blind, phase III LUCERNA trial.
Journal: ESMO gastrointestinal oncology
Published: August 12, 2026
Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study.
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Ultrasensitive circulating tumor DNA analysis improves detection of molecular residual disease in locally advanced esophageal cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 18, 2025
Acute Toxicity From Short-Course Radiation Therapy for Rectal Cancer: A Single-Institution Experience.
Journal: Advances in radiation oncology
Published: October 23, 2025
Open-Label, Phase II Trial of Extracellular Regulated Kinase Inhibition Alone and in Combination With Autophagy Inhibition in Patients With Metastatic Pancreatic Cancer.
Journal: JCO precision oncology
Published: September 02, 2025
Pembrolizumab plus chemotherapy versus chemotherapy for advanced esophageal cancer: 5-year extended follow-up for the randomized phase III KEYNOTE-590 study.
Journal: ESMO open
Published: July 25, 2025
Gastric Cancer, Version 2.2025, NCCN Clinical Practice Guidelines In Oncology.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: May 09, 2025
Genomic Landscape of Late-Stage Gastric Cancer: Analysis From KEYNOTE-059, KEYNOTE-061, and KEYNOTE-062 Studies.
Journal: JCO precision oncology
Published: March 21, 2025
The 2025 American Association for Thoracic Surgery (AATS) expert consensus document: Surgical management of esophageal and gastroesophageal junction cancer.
Journal: The Journal of thoracic and cardiovascular surgery
Published: February 18, 2025
Characterization of cell states in biliary tract cancers identifies mechanisms of therapeutic resistance in a phase II trial of DKN-01/nivolumab.
Journal: medRxiv : the preprint server for health sciences
Published: October 17, 2024
Health-related quality of life with bemarituzumab plus mFOLFOX6 in patients with FGFR2b-overexpressing, advanced gastric or gastroesophageal junction cancer.
Journal: ESMO gastrointestinal oncology
Published: October 08, 2024
Last Updated: 09/26/2026